Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 265 is a **nonfunctional genetic element** in the human genome related to the 5S ribosomal RNA gene. Pseudogenes such as RNA5SP265 resemble true protein- or RNA-coding genes but contain disabling mutations or lack regulatory elements required for expression, and thus do not produce functional products[2][6]. The canonical 5S rRNA gene is essential for assembling the large ribosomal subunit and protein synthesis[1][5], but pseudogenes like RNA5SP265 are generally considered *genomic fossils* without a known biological or disease-modifying role. There is no evidence that RNA5SP265 acts as a receptor, enzyme, or therapeutic target, nor is it implicated as a clinically relevant biomarker or drug-interaction partner. The entry “RNA, 5S ribosomal pseudogene 265” is **not** a protein, receptor, enzyme, or molecular target in the conventional sense. Pseudogenes can occasionally play indirect regulatory roles (e.g., as competitive endogenous RNAs in some cancers)[4][6], but there is no published evidence of such a function for this specific gene.
None (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 265 (RNA5SP265).